Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia - Wikidata - awgldk - TriplyDB

Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia

Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia

http://www.wikidata.org/entity/Q34627635

about

Respiratory challenge MRI: Practical aspects Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.Effects of aging on slow-wave sleep dynamics and human spatial navigational memory consolidation.The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.Subtle alterations in cerebrovascular reactivity in mild cognitive impairment detected by graph theoretical analysis and not by the standard approach Interactive effects of vascular risk burden and advanced age on cerebral blood flow.Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5 Measuring cerebrovascular reactivity: what stimulus to use?Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease Vascular risk factors, cerebrovascular reactivity, and the default-mode brain network Baseline cardiovascular risk predicts subsequent changes in resting brain function.Structural and physiological MRI correlates of occult cerebrovascular disease in late-onset epilepsy.Comparison of cerebral vascular reactivity measures obtained using breath-holding and CO2 inhalation The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairment Use of total cerebral blood flow as an imaging biomarker of known cardiovascular risks Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia.Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review.Frontocingulate cerebral blood flow and cerebrovascular reactivity associated with antidepressant response in late-life depression.Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors.Magnetic resonance imaging for assessment of cerebrovascular reactivity and its relationship to cognition: a systematic review.Regional Cerebrovascular Reactivity and Cognitive Performance in Healthy Aging.

P2860

Q26743484-3280D081-EA64-41F2-AD4B-25DE44220FA6 Q30235369-7F10C6CD-3A9D-484D-8A91-E29B2F5FC962 Q30597321-87BE7D31-92E5-4A94-A4FC-34DD3636AC47 Q30753258-B0B8A848-92A2-479F-84A1-984C92759608 Q31048037-655A05D9-5C23-4930-ACB3-24977C38AC18 Q33676184-268C0675-6372-43D4-8B9B-9802DEAC6457 Q33851687-63354430-1530-483F-9ACB-93E82175665F Q34275490-409446B4-1978-41C4-9661-1D0232313793 Q34483568-33F40265-4AD7-489A-A242-7DADA28A5D83 Q35002943-22A65D0B-2287-4531-AFA8-5D31AF1DB421 Q35143533-699B2AAD-DE47-4B46-989B-0D420C846882 Q35747415-E93574FE-DF25-4BA1-9152-D4517504D521 Q35992284-383E2F66-C9B1-49C1-B2DD-767B1E0EC070 Q36017149-56111658-89D6-42A1-954F-F68B84409372 Q36994320-7538E812-450E-47BB-9430-5B1ED1933B2C Q37185666-C0C0405E-DA10-4DCA-88EE-A785A151E9A9 Q37254592-5782BE97-DC87-4E55-81A7-DA44F834102F Q37351277-920406D1-F631-46BB-8DF9-49D1D674CC60 Q38742995-4229AAE6-2CAF-407C-9F54-467DAEED9040 Q39410816-704CE122-3A96-4161-B0A6-9851CD690232 Q47939728-0E7AB53A-E5EE-4974-86B6-DB625FFA2EB6 Q48325121-93E3E32E-FA46-48D0-9A62-430433BABE55 Q50655715-6F8DE5AB-F377-433D-895D-086547D1BD9B Q54966443-E31E72E3-E454-4C6A-8112-C28C816D4018 Q55709735-7EE20795-EF59-4FC7-AD03-5B3A53227081

P2860

Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia

http://www.wikidata.org/entity/Q34627635

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@ast

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@en

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@nl

type

label

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@ast

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@en

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@nl

prefLabel

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@ast

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@en

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@nl

P1433

Q34627635-45D86E5D-EFFB-4550-9FEF-4AE368CD6173

P1476

Q34627635-58C14E2D-2583-4F77-9EFA-60A109919B5E

P2093

Q34627635-209A5C36-15FC-4D64-9232-C1A4D3382798

Q34627635-42D2F0BA-1F6F-49E8-8D35-F6ED65AE407B

Q34627635-4C4BB9CD-D0D1-458E-AE0C-F220B37B4951

Q34627635-5ED335AB-E48E-4E13-A3D5-E2CB4AD09C50

Q34627635-9A984E8C-1DFA-41D8-AE28-0E7AC1759136

Q34627635-9BA2ABE6-CB46-4216-8E65-71774FC79AB7

Q34627635-A34935F5-DAB4-4FA7-8DD3-663E35DBC3EE

Q34627635-DB3E3DA1-F0D0-4545-B289-0E9A945DFD39

P2860

Q34627635-10078B77-33FF-42B8-88E9-039F94BB65C4

Q34627635-10C2666A-6952-43A8-90F5-E0FD32B99708

Q34627635-16451BDB-80EC-4785-8012-B7038728E4FE

Q34627635-18F4865D-F90B-42F5-9508-8969AFAF5329

Q34627635-1C2B122D-A974-4C86-A676-595430BC733E

Q34627635-23022345-3955-414D-AB51-752267619788

Q34627635-2DA29CE7-BCAB-4CD7-8CBD-31AF831A6592

Q34627635-31C19308-475B-423C-89F8-555639903E56

Q34627635-417741C9-3887-401E-9636-B02C5A6C102A

Q34627635-4C2C6386-C005-4E7F-81CE-F332834C8F2E

P304

Q34627635-AF72A2FA-1452-47D0-A6A7-883A82F0F54F

P31

Q34627635-5D972737-2DAB-4193-8E8E-6D349D6348EA

P356

Q34627635-489F7756-80F0-4123-8D80-C9ADF125CD38

P433

Q34627635-A5D73708-C788-4F1D-A1BE-EF56C0BF8853

P478

Q34627635-7F3B2B95-15F0-4059-9FF0-A72D097179E7

P50

Q34627635-4880A022-656A-47CF-BAA9-0DA06CC1D9E8

Q34627635-54D65324-CA38-401D-9C8C-83172A290AB9

Q34627635-7B1CD92D-BD75-49FB-9F9E-72B001F149E6

Q34627635-91F6BD2D-FA13-4CA0-85F2-77FEAC0269AB

P577

Q34627635-7C249780-F98E-4236-8F9F-708697755154

P5875

Q34627635-668D0E99-E617-4BF1-8805-4DDAB8FE2034

P698

Q34627635-B84FA746-1322-4CD3-AF70-BF23BF68E2BE

P921

Q34627635-1977CCF6-98AF-45D3-8A0F-86EEEC3C70F0

Q34627635-D7613DBA-7063-438D-B8E7-6721ED1CAB0B

P932

Q34627635-C932133C-669C-482A-B4A5-8127463996A0

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Framingham cardiovascular risk ...... vasoreactivity to hypercapnia

@en

P2093

Alexander Goldowsky

http://www.w3.org/2001/XMLSchema#string

Elizabeth Pirraglia

http://www.w3.org/2001/XMLSchema#string

Henry Rusinek

http://www.w3.org/2001/XMLSchema#string

Lisa Mosconi

http://www.w3.org/2001/XMLSchema#string

Rachel Mistur

http://www.w3.org/2001/XMLSchema#string

Remigiusz Switalski

http://www.w3.org/2001/XMLSchema#string

Susan de Santi

http://www.w3.org/2001/XMLSchema#string

Wai H Tsui

http://www.w3.org/2001/XMLSchema#string

P2860

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Voxel-based morphometry--the methods

Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: II. Normal values and gray matter blood flow response to visual activation.

Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison.

Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin.

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Quantifying CBF with arterial spin labeling.

The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease.

Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques.

Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging

P304

671-679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2010.145

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46273893

http://www.w3.org/2001/XMLSchema#string

P698

20842159

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3049521

http://www.w3.org/2001/XMLSchema#string